LG Chem starts to aim for rheumatoid arthritis market
LG Chem will start to aim for the Korean rheumatoid arthritis market.
LG Chem announced on the 28th that the company start to sell a rheumatoid arthritis therapy ‘Eucept(generic name: etanercept)’ in Korea.
Eucept, the LG Chem’s first antibody, was approved for the treatment of ▲rheumatoid arth...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
